Showing 3,101 - 3,120 results of 9,864 for search '"drug"', query time: 0.09s Refine Results
  1. 3101

    Mechanistic Insights into the Anticancer Potential of Methoxyflavones Analogs: A Review by Mohammad Aidiel, Maisarah Abdul Mutalib, Rajesh Ramasamy, Nik Nasihah Nik Ramli, Shirley Gee Hoon Tang, Siti Hajar Adam

    Published 2025-01-01
    “…However, the lipophilic nature of these analogs is a key concern as it impacts drug membrane transfer. While lipophilicity is crucial for drug efficacy, the excessive lipophilic effects in flavonoids can reduce water solubility and hinder drug transport to target sites. …”
    Get full text
    Article
  2. 3102

    Comparison of clinical and pharmacodynamic features of proton pump inhibitors efficacy in gastroesophageal reflux disease by O. A. Storonova, A. S. Trukhmanov

    Published 2015-12-01
    “…Intensity of acid-suppressive action of PPI depends on drug metabolic pathways and genetically determined features of cytochrome P450 system. …”
    Get full text
    Article
  3. 3103

    A Comprehensive Review on Pharmacotherapeutics of Herbal Bioenhancers by Ghanshyam B. Dudhatra, Shailesh K. Mody, Madhavi M. Awale, Hitesh B. Patel, Chirag M. Modi, Avinash Kumar, Divyesh R. Kamani, Bhavesh N. Chauhan

    Published 2012-01-01
    “…In India, Ayurveda has made a major contribution to the drug discovery process with new means of identifying active compounds. …”
    Get full text
    Article
  4. 3104
  5. 3105

    Cardiovascular Safety of Clonidine and Dexmedetomidine in Critically Ill Patients after Cardiac Surgery by Angelina Grest, Judith Kurmann, Markus Müller, Victor Jeger, Bernard Krüger, Donat R. Spahn, Dominique Bettex, Alain Rudiger

    Published 2020-01-01
    “…Dexmedetomidine and the low-cost drug clonidine can both be used safely in selected patients after cardiac surgery.…”
    Get full text
    Article
  6. 3106

    Association of AGTR1 A1166C and CYP2C9∗3 Gene Polymorphisms with the Antihypertensive Effect of Valsartan by Yi Liu, Xiaomu Kong, Yongwei Jiang, Meimei Zhao, Peng Gao, Xiao Cong, Yongtong Cao, Liang Ma

    Published 2022-01-01
    “…The differences in the antihypertensive treatment with angiotensin type II receptor blockers (ARBs) may be attributed to polymorphisms in genes involving drug-targeted receptor and drug metabolism. The present study aimed to investigate whether the antihypertensive effect of the ARB drug valsartan was associated with angiotensin II type 1 receptor (AGTR1) gene polymorphism (A1166 C) and cytochrome P450 enzyme 2C9 (CYP2C9) gene polymorphism (CYP2C9∗3). …”
    Get full text
    Article
  7. 3107

    Reduction of monoclonal antibody viscosity using interpretable machine learning by Emily K. Makowski, Hsin-Ting Chen, Tiexin Wang, Lina Wu, Jie Huang, Marissa Mock, Patrick Underhill, Emma Pelegri-O’Day, Erick Maglalang, Dwight Winters, Peter M. Tessier

    Published 2024-12-01
    “…Early identification of antibody candidates with drug-like properties is essential for simplifying the development of safe and effective antibody therapeutics. …”
    Get full text
    Article
  8. 3108

    A state-of-the-art review of the recent advances of theranostic liposome hybrid nanoparticles in cancer treatment and diagnosis by Hannaneh Azimizonuzi, Arman Ghayourvahdat, Mareb Hamed Ahmed, Radhwan Abdul Kareem, Athmar Jaber Zrzor, Aseel Salah Mansoor, Zainab H. Athab, Shaylan Kalavi

    Published 2025-01-01
    “…Liposomes (LPs) are one of the most efficient drug delivery methods based on nanotechnology. Stealth LPs and commercial LPs have recently had an impact on cancer treatment. …”
    Get full text
    Article
  9. 3109
  10. 3110

    Formulation and In Vitro Evaluation of Oral Capsules from Liquid Herbal Antimalarials Marketed in Ghana by Christina Osei-Asare, Fredrick William Akuffo Owusu, Philomena Entsie, Ama Kwansima Annan, Rita Akosua Gyamaa, Edem Makafui Amenuke

    Published 2021-01-01
    “…All formulated capsules had ƒ2 values >50 and ƒ1 values <15, indicating the similarity of their drug release profiles with their respective liquid herbal antimalarials. …”
    Get full text
    Article
  11. 3111

    hERG activators exhibit antitumor effects in breast cancer through calcineurin and β-catenin-mediated signaling pathways by Yan Yu, Chengchun Zhu, Xiao Wang, Ying Shi, Yiping Gao, Zhiyi Yu

    Published 2025-01-01
    “…This highlights the need for novel drug candidates with new mechanisms of action by targeting alternative signaling pathways. …”
    Get full text
    Article
  12. 3112
  13. 3113

    NS5A replication complex inhibitor daclatasvir in the basis of chronic hepatitis C interferon-free therapy by M. V. Mayevskaya, M. S. Zharkova, V. T. Ivashkin

    Published 2015-12-01
    “…A safety profile and tolerability of daclatasvir is good, comparable to placebo group. The drug is not registered in Russia yet, its approval in combination to asunaprevir is expected soon.Conclusion. …”
    Get full text
    Article
  14. 3114

    Microbial-based natural products as potential inhibitors targeting DNA gyrase B of Mycobacterium tuberculosis: an in silico study by Tilal Elsaman, Magdi Awadalla Mohamed, Malik Suliman Mohamed, Eyman Mohamed Eltayib, Abualgasim Elgaili Abdalla

    Published 2025-01-01
    “…IntroductionSince the emergence of Mycobacterium tuberculosis (MBT) strains resistant to most currently used anti-tubercular drugs, there has been an urgent need to develop efficient drugs capable of modulating new therapeutic targets. …”
    Get full text
    Article
  15. 3115

    Safety and Phosphate‐Binding Capacity of Oxylanthanum Carbonate in Healthy Volunteers by Pablo E. Pergola, Melanie S. Joy, Armando Garsd, Steve J. Hasal, Atul Khare, Guru Reddy, Pramod Gupta, William F. Finn

    Published 2025-01-01
    “…Oxylanthanum carbonate is a new molecule yielding the same phosphate‐binding capacity as lanthanum carbonate, but in a much smaller drug volume and tablet size. It is formulated as small tablets that can be easily swallowed. …”
    Get full text
    Article
  16. 3116

    A pH-responsive PROTAC-based nanosystem triggers tumor-specific ferroptosis to construct in situ tumor vaccines by Linghong Huang, Xinyuan Sun, Qinhua Zuo, Ting Song, Ning Liu, Zonghua Liu, Wei Xue

    Published 2025-04-01
    “…The selected PROTAC drug (ARV-825) can specifically degrade BRD4 without harming immune cells. …”
    Get full text
    Article
  17. 3117

    Promising LOX proteins for cartilage-targeting osteoarthritis therapy by Luca Morici, Eric Allémann, Olivier Jordan, Ines Nikolić

    Published 2025-02-01
    “…This review, therefore, proposes promising strategies for future drug development in OA treatment.…”
    Get full text
    Article
  18. 3118

    Numerical Studies of Particle-Gas Two-Phase Flowing through Microshock Tubes by Guang Zhang, Wei Wei Wang, Xiang Hui Su, Xiao Jun Li, Wen Hao Shen, Zhe Lin

    Published 2021-01-01
    “…Microshock tubes are always used to induce shock waves and supersonic flows in aerospace and medical engineering fields. A needle-free drug delivery device including a microshock tube and an expanded nozzle is used for delivering solid drug powders through the skin surface without any injectors or pain. …”
    Get full text
    Article
  19. 3119

    Bilosomal Co-Encapsulated Tamoxifen and Propranolol for Potentiated Anti-Breast Cancer Efficacy: In Vitro and In Vivo Investigation by Toka T. Elebyary, Amal A. Sultan, Sally E. Abu-Risha, Gamal M. El Maghraby, Manna Amin

    Published 2025-01-01
    “…<b>Background/Objectives</b>: Tamoxifen (TAM) is an anti-breast cancer drug suffering from acquired resistance development, prompting cancer relapse. …”
    Get full text
    Article
  20. 3120

    Targeting Glutathione-S Transferase Enzymes in Musculoskeletal Sarcomas: A Promising Therapeutic Strategy by Michela Pasello, Maria Cristina Manara, Francesca Michelacci, Marilù Fanelli, Claudia Maria Hattinger, Giordano Nicoletti, Lorena Landuzzi, Pier Luigi Lollini, Annamaria Caccuri, Piero Picci, Katia Scotlandi, Massimo Serra

    Published 2011-01-01
    “…By using a panel of 15 drug-sensitive and drug-resistant human osteosarcoma, Ewing's sarcoma, and rhabdomyosarcoma cell lines, the efficay of the GST-targeting agent 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol (NBDHEX) has been assessed and related to GST isoenzymes expression (namely GSTP1, GSTA1, GSTM1, and MGST). …”
    Get full text
    Article